Raman Self‐Tracking Copper Metal‐Organic Framework‐Based Nanoplatform for Cuproptosis Cancer Therapy
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.9809366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Yujie Duan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Polymer Science and Technology, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Aca…. Hauptthemen laut MEDLINE: Copper, Cuproptosis, Antineoplastic Agents, Metal-Organic Frameworks. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cuproptosis represents a promising strategy for cancer therapy, yet its clinical translation is hampered by unexpected deactivation and off‐target toxicity of copper ions during their delivery to tumors. We developed a copper metal‐organic framework‐based nanoplatform (CuF) with H 2 O 2 responsiveness and Raman self‐tracking capability for cuproptosis‐mediated antitumor therapy. CuF was prepared by coordinating Cu 2+ with an alkyne‐bearing ligand, followed by PEGylation and incorporation of an iron‐based catalyst. CuF undergoes catalyst‐mediated oxidative cleavage of alkynyl bonds under tumor‐associated elevated H 2 O 2 levels, causing CuF degradation and Cu 2+ release. Released Cu 2+ causes copper overload in tumor cells, thereby inducing potent cuproptosis. Meanwhile, the resultant aldehydes and acids generated by the oxidative cleavage of alkynes can further synergistically potentiate cuproptosis. Consequently, CuF demonstrated high antitumor efficacy in a 4T1 tumor‐bearing mouse model (with a tumor inhibition rate of 91%). Moreover, alkynes in the metal‐organic framework (MOF) backbone provided an intrinsically enhanced Raman signal, enabling label‐free self‐tracking of CuF distribution and degradation in cells and tissue sections through Raman imaging. Overall, this work not only provides a new paradigm for cuproptosis‐based anticancer agents, but also offers a versatile strategy for engineering H 2 O 2 responsive materials and Raman imaging nanoplatforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Polymer Science and Technology, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, P. R. China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, P. R. China.
- Department of Breast Surgery, Second Hospital of Jilin University, Changchun, P. R. China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
ORCID-Profile: Yujie Duan, Hao Wang, Chunsheng Xiao, Xuesi Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Duan, Y., Bao, Y., Gao, Z., He, X., Liu, X., Wang, H., Xiao, C., & Chen, X. (2026). Raman Self‐Tracking Copper Metal‐Organic Framework‐Based Nanoplatform for Cuproptosis Cancer Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.9809366
Vancouver
Duan Y, Bao Y, Gao Z, He X, Liu X, Wang H, et al. Raman Self‐Tracking Copper Metal‐Organic Framework‐Based Nanoplatform for Cuproptosis Cancer Therapy. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.9809366
BibTeX
@article{Duan2026,
author = {Duan, Yujie and Bao, Ying and Gao, Ziwen and He, Xidong and Liu, Xinming and Wang, Hao and Xiao, Chunsheng and Chen, Xuesi},
title = {Raman Self‐Tracking Copper Metal‐Organic Framework‐Based Nanoplatform for Cuproptosis Cancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.9809366}
}
EUVIMED